We are live on ! Find out more
WBA

Walgreens Boots Alliance

Delisted

WBA was delisted on the 27th of August, 2025.

1,307 hedge funds and large institutions have $55B invested in Walgreens Boots Alliance in 2017 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 452 increasing their positions, 530 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $564M

24% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 72

1% more capital invested

Capital invested by funds: $54.4B → $55B (+$626M)

0.46% more ownership

Funds ownership: 60.96%61.42% (+0.46%)

0% more funds holding

Funds holding: 1,3041,307 (+3)

15% less repeat investments, than reductions

Existing positions increased: 452 | Existing positions reduced: 530

18% less funds holding in top 10

Funds holding in top 10: 6755 (-12)

Holders
1,307
Holders Change
+3
Holders Change %
+0.23%
% of All Funds
32.54%
Holding in Top 10
55
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-17.91%
% of All Funds
1.37%
New
89
Increased
452
Reduced
530
Closed
72
Calls
$1.11B
Puts
$564M
Net Calls
+$541M
Net Calls Change
+$98.1M
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
1301
Watermark Asset Management
California
$3K +$3.02K +36 New
MDCM
1302
Morgan Dempsey Capital Management
Wisconsin
$3K +$3.52K +42 New
CT
1303
Chicago Trust
Illinois
$2.37K -$204K -2,435 -8%
MCM
1304
MV Capital Management
Maryland
$2K
SM
1305
Sciencast Management
New Jersey
$1.31K +$793K +9,452 +148%
Walleye Trading
1306
Walleye Trading
New York
$696 +$703K +8,383 New
NDSI
1307
Newman Dignan & Sheerar Inc
Rhode Island
$538
SLF
1308
Sun Life Financial
Ontario, Canada
$460
SSA
1309
South Street Advisors
New York
$406
GCM
1310
Glenview Capital Management
New York
-$124M -1,500,000 Closed
FTCM
1311
Fir Tree Capital Management
New York
-$123M -1,483,411 Closed
YCMGA
1312
York Capital Management Global Advisors
New York
-$84.9M -1,025,378 Closed
PHS
1313
PFM Health Sciences
California
-$53.4M -645,665 Closed
Alkeon Capital Management
1314
Alkeon Capital Management
New York
-$49.7M -600,150 Closed
PC
1315
Polar Capital
United Kingdom
-$34.1M -412,000 Closed
OCAM
1316
Onex Canada Asset Management
Ontario, Canada
-$29.5M -356,940 Closed
HCM
1317
Hoplite Capital Management
New York
-$28.6M -345,607 Closed
Fidelity International
1318
Fidelity International
Bermuda
-$27.6M -333,048 Closed
SP
1319
Sarasin & Partners
United Kingdom
-$26.1M -314,974 Closed
DKCM
1320
Davidson Kempner Capital Management
New York
-$21M -253,120 Closed
OCA
1321
Otter Creek Advisors
Florida
-$17.2M -208,335 Closed
ELI
1322
Empire Life Investments
Ontario, Canada
-$11.1M -139,036 Closed
EWA
1323
EP Wealth Advisors
California
-$8.16M -110,192 Closed
Hudson Bay Capital Management
1324
Hudson Bay Capital Management
Connecticut
-$6.45M -77,900 Closed
Two Sigma Advisers
1325
Two Sigma Advisers
New York
-$6.36M -76,821 Closed

WBA Hedge Fund Activity: Q1 2017 in Review

1,307 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Walgreens Boots Alliance (WBA) for Q1 2017, worth a combined $55B — up 1.1% from $54.4B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new WBA positions and 72 closed out — a net gain of 17 holders — while 452 added to existing stakes and 530 trimmed.

The largest buyer was BlackRock, adding an estimated $4.46B. The largest seller was T. Rowe Price Associates, cutting an estimated $474M.

  • 1,307 institutional investors held Walgreens Boots Alliance (WBA) as of Q1 2017, up from 1,304 in Q4 2016.
  • Funds reported $55B of Walgreens Boots Alliance stock for Q1 2017, up 1.1% quarter-over-quarter.
  • 89 funds opened new Walgreens Boots Alliance positions in Q1 2017 and 72 closed out, a net change of +17 holders.
  • The largest Walgreens Boots Alliance buyer in Q1 2017 was BlackRock, an estimated $4.46B added.
  • The largest Walgreens Boots Alliance seller in Q1 2017 was T. Rowe Price Associates, an estimated $474M sold.

Based on aggregated 13F filings for Q1 2017.